Copywriter

Responsibilities: Develop compelling, brand‑aligned copy for multi‑channel marketing campaigns, including digital, social, email, SMS, direct mail, and event materials. Write and edit content for thought leadership assets (white papers, blogs, webinars), executive communications, and sales enablement tools. Collaborate with creative teams, content managers, and campaign leads to ensure messaging consistency across B2B, B2C, and B2Provider audiences. Adapt complex healthcare and product information into clear, engaging language for diverse audiences while maintaining compliance and accessibility standards. Support AI‑enabled workflows for drafting and optimization, applying human review for accuracy, tone, and regulatory adherence. Maintain company Rx brand voice and style guidelines across all content; contribute to updates and refinements. Participate in content QA and approval processes, ensuring accuracy, compliance (HIPAA, fair balance), and readability. Assist in performance reviews of content (engagement metrics, A/B test results) and incorporate insights into future copy. Qualifications: 3–5+ years of experience in copywriting or content development within marketing, advertising, or healthcare in English. Strong portfolio demonstrating ability to write for digital, social, email, and print channels. Excellent writing, editing, and proofreading skills with attention to detail and brand voice. Familiarity with healthcare terminology, compliance requirements, and accessibility standards. Experience collaborating with creative teams and using content management systems; knowledge of AI tools for content creation preferred. Ability to manage multiple projects and deadlines in a fast‑paced environment. Bachelors degree in marketing, communications, journalism, or related field. Work Set-up: Hybrid Schedule: Night Shift Locations: Metro Manila By Applying, you give consent to collect, store, and/or process personal and/or sensitive information for the purpose of recruitment and employment may it be internal to Cobden & Carter International and/or to its clients